Metabolic profiling in human exposome studies

Mutagenesis

Volumn 30, Issue 6, 2015, Pages 755-762

  Athersuch, Toby J ^a,b   Keun, Hector C ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Faculty of Medicine and MRC Health Protection Agency   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CHRONIC DISEASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENVIRONMENTAL HEALTH; EXPOSOME; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; METABOLISM; METABOLOME; METABOLOMICS; METABONOMICS; MOLECULAR BIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; ANIMAL; DISEASE PREDISPOSITION; PROCEDURES; RESEARCH;

ANIMALS; DISEASE SUSCEPTIBILITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; GENE-ENVIRONMENT INTERACTION; HUMANS; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; RESEARCH;

EID: 84982094982     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gev060     Document Type: Review

References (71)

1. Visscher, P. M., Brown, M. A., McCarthy, M. I. and Yang, J. (2012) Five years of GWAS discovery. Am. J. Hum. Genet., 90, 7-24
2. Willett, W. C. (2002) Balancing life-style and genomics research for disease prevention. Science, 296, 695-698
3. Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A. and Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85
4. Lozano, R., Naghavi, M., Foreman, K., et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2095-2128
5. Ezzati, M. and Riboli, E. (2013) Behavioral and dietary risk factors for noncommunicable diseases. N. Engl. J. Med., 369, 954-964
6. Kontis, V., Mathers, C. D., Rehm, J., et al. (2014) Contribution of six risk factors to achieving the 25 × 25 non-communicable disease mortality reduction target: a modelling study. Lancet, 384, 427-437
7. Elliott, P. and Wartenberg, D. (2004) Spatial epidemiology: current approaches and future challenges. Environ. Health Perspect., 112, 998-1006
8. Vineis, P., van Veldhoven, K., Chadeau-Hyam, M. and Athersuch, T. J (2013) Advancing the application of omics-based biomarkers in environmental epidemiology. Environ. Mol. Mutagen., 54, 461-467
9. Wild, C. P. (2005) Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomarkers Prev., 14, 1847-1850
10. Rappaport, S. M. (2011) Implications of the exposome for exposure science J. Expo. Sci. Environ. Epidemiol., 21, 5-9
11. Rappaport, S. M. (2012) Biomarkers intersect with the exposome. Biomarkers, 17, 483-489
12. Smith, M. T. and Rappaport, S. M. (2009) Building exposure biology centers to put the E into "G x E" interaction studies. Environ. Health Perspect., 117, A334-A335
13. Rappaport, S. M. (2012) Discovering environmental causes of disease. J Epidemiol. Community Health, 66, 99-102
14. Rappaport, S. M. and Smith, M. T. (2010) Epidemiology. Environment and disease risks. Science, 330, 460-461
15. Lioy, P. J. and Rappaport, S. M. (2011) Exposure science and the exposome: an opportunity for coherence in the environmental health sciences Environ. Health Perspect., 119, A466-A467
16. Miller, G. W. and Jones, D. P. (2014) The nature of nurture: refining the definition of the exposome. Toxicol. Sci., 137, 1-2
17. Oliver, S. G., Winson, M. K., Kell, D. B. and Baganz, F. (1998) Systematic functional analysis of the yeast genome. Trends Biotechnol., 16, 373-378
18. Fiehn, O. (2001) Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp. Funct Genomics, 2, 155-168
19. Nicholson, J. K., Lindon, J. C. and Holmes, E. (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica., 29, 1181-1189
20. Holmes, E., Loo, R. L., Cloarec, O., et al. (2007) Detection of urinary drug metabolite (xenometabolome) signatures in molecular epidemiology studies via statistical total correlation (NMR) spectroscopy. Anal. Chem., 79, 2629-2640
21. Wild, C. P. (2012) The exposome: from concept to utility. Int. J. Epidemiol., 41, 24-32
22. Wild, C. P., Scalbert, A. and Herceg, Z. (2013) Measuring the exposome: a powerful basis for evaluating environmental exposures and cancer risk Environ. Mol. Mutagen., 54, 480-499
23. Athersuch, T. J. (2012) The role of metabolomics in characterizing the human exposome. Bioanalysis, 4, 2207-2212
24. Wishart, D. S., Knox, C., Guo, A. C., et al. (2009) HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res., 37, D603-D610
25. Wishart, D. S., Jewison, T., Guo, A. C., et al. (2013) HMDB 3.0-The Human Metabolome Database in 2013. Nucleic Acids Res., 41, D801-D807
26. Wang, Y., Huang, H., Sun, M., Zhang, Q. and Guo, D. (2012) T3DB: an integrated database for bacterial type III secretion system. BMC Bioinformatics, 13, 66
27. Law, V., Knox, C., Djoumbou, Y., et al. (2014) DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res., 42, D1091-D1097
28. Wang, Y., Xiao, J., Suzek, T. O., Zhang, J., Wang, J. and Bryant, S. H (2009) PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res., 37, W623-W633
29. Li, Q., Cheng, T., Wang, Y. and Bryant, S. H. (2010) PubChem as a public resource for drug discovery. Drug Discov. Today, 15, 1052-1057
30. Gaulton, A., Bellis, L. J., Bento, A. P., et al. (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res., 40, D1100-D1107
31. Nicholson, J. K. and Wilson, I. D. (2003) Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev. Drug Discov., 2, 668-676
32. Rappaport, S. M., Barupal, D. K., Wishart, D., Vineis, P. and Scalbert, A (2014) The blood exposome and its role in discovering causes of disease Environ. Health Perspect., 122, 769-774
33. Lindon, J. C. and Nicholson, J. K. (2008) Analytical technologies for metabonomics and metabolomics, and multi-omic information recovery Trends Anal. Chem., 27, 194-204
34. Psychogios, N., Hau, D. D., Peng, J., et al. (2011) The human serum metabolome PLoS One, 6, e16957
35. Bouatra, S., Aziat, F., Mandal, R., et al. (2013) The human urine metabolome PLoS One, 8, e73076
36. Beckonert, O., Keun, H. C., Ebbels, T. M., Bundy, J., Holmes, E., Lindon, J. C. and Nicholson, J. K. (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc., 2, 2692-2703
37. Want, E. J., Wilson, I. D., Gika, H., Theodoridis, G., Plumb, R. S., Shockcor, J., Holmes, E. and Nicholson, J. K. (2010) Global metabolic profiling procedures for urine using UPLC-MS. Nat. Protoc., 5, 1005-1018
38. Ramautar, R., Toraño, J. S., Somsen, G. W. and de Jong, G. J. (2010) Evaluation of CE methods for global metabolic profiling of urine. Electrophoresis, 31, 2319-2327
39. Spagou, K., Wilson, I. D., Masson, P., et al. (2011) HILIC-UPLC-MS for exploratory urinary metabolic profiling in toxicological studies. Anal Chem., 83, 382-390
40. Chan, E. C., Pasikanti, K. K. and Nicholson, J. K. (2011) Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry Nat. Protoc., 6, 1483-1499
41. Roberts, L. D., Souza, A. L., Gerszten, R. E. and Clish, C. B. (2012) Targeted metabolomics. Curr. Protoc. Mol. Biol., 98, 30.2.1-30.2.24
42. Gika, H. G., Theodoridis, G. A., Earll, M. and Wilson, I. D. (2012) A QC approach to the determination of day-to-day reproducibility and robustness of LC-MS methods for global metabolite profiling in metabonomics/ metabolomics. Bioanalysis, 4, 2239-2247
43. Dunn, W. B., Broadhurst, D., Begley, P., et al. (2011) Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc., 6, 1060-1083
44. Dunn, W. B., Wilson, I. D., Nicholls, A. W. and Broadhurst, D. (2012) The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. Bioanalysis, 4, 2249-2264
45. Teahan, O., Gamble, S., Holmes, E., Waxman, J., Nicholson, J. K., Bevan, C. and Keun, H. C. (2006) Impact of analytical bias in metabonomic studies of human blood serum and plasma. Anal. Chem., 78, 4307-4318
46. Hebels, D. G., Georgiadis, P., Keun, H. C., et al. (2013) Performance in omics analyses of blood samples in long-term storage: opportunities for the exploitation of existing biobanks in environmental health research Environ. Health Perspect., 121, 480-487
47. Yu, Z., Kastenmüller, G., He, Y., et al. (2011) Differences between human plasma and serum metabolite profiles. PLoS One, 6, e21230
48. Barri, T. and Dragsted, L. O. (2013) UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant. Anal. Chim. Acta, 768, 118-128
49. Patel, C. J., Bhattacharya, J. and Butte, A. J. (2010) An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus. PLoS One, 5, e10746
50. Ellis, J. K., Athersuch, T. J., Thomas, L. D., et al. (2012) Metabolic profiling detects early effects of environmental and lifestyle exposure to cadmium in a human population. BMC Med., 10, 61
51. Thomas, L. D., Hodgson, S., Nieuwenhuijsen, M. and Jarup, L. (2009) Early kidney damage in a population exposed to cadmium and other heavy metals. Environ. Health Perspect., 117, 181-184
52. Chadeau-Hyam, M., Athersuch, T. J., Keun, H. C., et al. (2011) Meetingin- the-middle using metabolic profiling - a strategy for the identification of intermediate biomarkers in cohort studies. Biomarkers, 16, 83-88
53. Wang, T. J., Larson, M. G., Vasan, R. S., et al. (2011) Metabolite profiles and the risk of developing diabetes. Nat. Med., 17, 448-453
54. Wang, Z., Klipfell, E., Bennett, B. J., et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 472, 57-63
55. Tang, W. H., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y. and Hazen, S. L. (2013) Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med., 368, 1575-1584
56. Koeth, R. A., Wang, Z., Levison, B. S., et al. (2013) Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis Nat. Med., 19, 576-585
57. Koeth, R. A., Levison, B. S., Culley, M. K., et al. (2014) γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab., 20, 799-812
58. Robinette, S. L., Holmes, E., Nicholson, J. K. and Dumas, M. E. (2012) Genetic determinants of metabolism in health and disease: from biochemical genetics to genome-wide associations. Genome Med., 4, 30
59. Suhre, K. and Gieger, C. (2012) Genetic variation in metabolic phenotypes: study designs and applications. Nat. Rev. Genet., 13, 759-769
60. Suhre, K., Wallaschofski, H., Raffler, J., et al. (2011) A genome-wide association study of metabolic traits in human urine. Nat. Genet., 43, 565-569
61. Suhre, K., Shin, S. Y., Petersen, A. K., et al.; CARDIoGRAM. (2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature, 477, 54-60
62. Wichmann, H. E., Spector, T. D., Adamski, J. and Suhre, K. (2010) A genome-wide perspective of genetic variation in human metabolism Nature, 42, 137-141
63. Shin, S. Y., Fauman, E. B., Petersen, A. K., et al. (2014) An atlas of genetic influences on human blood metabolites. Nat. Genet., 46, 543-550
64. Rueedi, R., Ledda, M., Nicholls, A. W., et al. (2014) Genome-wide association study of metabolic traits reveals novel gene-metabolite-disease links PLoS Genet., 10, e1004132
65. Petersen, A. K., Zeilinger, S., Kastenmüller, G., et al. (2014) Epigenetics meets metabolomics: an epigenome-wide association study with blood serum metabolic traits. Hum. Mol. Genet., 23, 534-545
66. Potera, C. (2014) The HELIX Project: tracking the exposome in real time Environ. Health Perspect., 122, A169
67. Vrijheid, M., Slama, R., Robinson, O., et al. (2014) The human early-life exposome (HELIX): project rationale and design. Environ. Health Perspect., 122, 535-544
68. Dwivedi, P., Wu, P., Klopsch, S. J., Puzon, G. J., Xun, L. and Hill, H. H., Jr (2008) Metabolic profiling by ion mobility mass spectrometry (IMMS) Metabolomics, 4, 63-80
69. Harry, E. L., Weston, D. J., Bristow, A. W., Wilson, I. D. and Creaser, C. S (2008) An approach to enhancing coverage of the urinary metabonome using liquid chromatography-ion mobility-mass spectrometry. J. Chromatogr B. Analyt. Technol. Biomed. Life Sci., 871, 357-361
70. Dallmann, R., Viola, A. U., Tarokh, L., Cajochen, C. and Brown, S. A (2012) The human circadian metabolome. Proc. Natl. Acad. Sci. U. S. A., 109, 2625-2629
71. Davies, S. K., Ang, J. E., Revell, V. L., et al. (2014) Effect of sleep deprivation on the human metabolome. Proc. Natl. Acad. Sci. U. S. A., 111, 10761-10766.